We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
This week, a federal district court in New York allowed a putative antitrust class action against a group of Chinese vitamin C manufacturers to move forward, rejecting the defendants’ argument on summary judgment that they were compelled by the Chinese government to export vitamin C at a minimum price
Current Search
Workarea - Competition
Workarea - Litigation
Firm Name - Paul, Weiss, Rifkind, Wharton & Garrison LLP
